Congratulations to the 2025 CRA Awards of Distinction, CRA Master Awards ,Practice Reflection Award and Abstract Award Recipients!

Canadian Rheumatology Association (CRA) has negotiated an exclusive discount and 1-month free trials to rheumatology-optimized AI scribes through a partnership with top vendors Scribeberry and Heidi Health.

UPDATED: CRA Position Statement on Safety of Hydroxychloroquine in the Treatment of Rheumatic Diseases.

SAVE THE DATE: April 16-19, 2026. The 2026 Annual Scientific Meeting springs forward to April! Call for Workshop Proposals is now open! Deadline to submit is September 5, 2025.